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Summary
Learning through experience underlies the ability to adapt
to novel tasks and unfamiliar environments. However,
learning must be regulated so that relevant aspects of the
environment are selectively encoded. Acetylcholine (ACh)
has been suggested to regulate learning by enhancing the
responses of sensory cortical neurons to behaviorally
relevant stimuli [1]. In this study, we increased synaptic
levels of ACh in the brains of healthy human subjects with
the cholinesterase inhibitor donepezil (trade name: Aricept)
and measured the effects of this cholinergic enhancement
on visual perceptual learning. Each subject completed two
5 day courses of training on a motion direction discrimina-
tion task [2], once while ingesting 5 mg of donepezil before
every training session and once while placebo was adminis-
tered. We found that cholinergic enhancement augmented
perceptual learning for stimuli having the same direction of
motion and visual field location used during training. In addi-
tion, perceptual learning with donepezil was more selective
to the trained direction of motion and visual field location.
These results, combined with previous studies demon-
strating an increase in neuronal selectivity following cholin-
ergic enhancement [3–5], suggest a possible mechanism by
whichACh augments neural plasticity by directing activity to
populations of neurons that encode behaviorally relevant
stimulus features.
Results
The neurotransmitter acetylcholine (ACh) has been proposed
to regulate neural plasticity by selectively increasing the
responses of neurons to behaviorally relevant stimuli [1].
Cholinergic neurons in the basal forebrain project widely to
cortex, where they release more ACh when animals are
performing a task requiring sustained attention [6]. In addition,
application of ACh to sensory cortex induces persistent modi-
fications of neuronal tuning [7], and pairing of basal forebrain
electrical stimulation with presentation of a sensory stimulus
causes changes in cortical tuning that are similar to those
observed when the animal performs a task on the presented
stimulus [8]. In humans, pharmacological reduction of cholin-
ergic transmission has been shown to prevent learning-depen-
dent changes in fMRI responses [9]. Cholinesterase inhibitors
such as donepezil (trade name: Aricept) reduce the activity of
the enzyme that breaks downACh in the synaptic cleft, thereby
prolonging the effects of endogenously released ACh.
Previous results suggest that cholinesterase inhibitors may*Correspondence: arokem@berkeley.edubenefit cognitive functions such as attention and memory
[10, 11].
We examined the effects of cholinergic enhancement with
donepezil on perceptual learning of amotion direction discrim-
ination task [2]. Perceptual learning is a persistent and stim-
ulus-specific improvement in performance of a perceptual
task with training [12]. The specificity of perceptual learning
suggests possible changes in coding in neurons selectively
tuned to the characteristics of the training stimuli. Indeed,
physiological studies in humans [13] and other primates
[14–16] have described changes in coding in visual cortical
areas containing neurons exhibiting selectivity for the stimulus
characteristics employed during training.
Twelve participants (seven female; mean age: 23 6 6;
tobacco smokers were excluded from participation; all
subjects had normal or corrected-to-normal vision) performed
a task in which they reported whether two fields of moving
dots, presented sequentially, were moving in the same direc-
tion [2] (Figure 1A; see also Supplemental Experimental Proce-
dures available online). The angular difference between the
stimuli was adjusted according to a psychophysical staircase,
converging on 70% correct performance, and a threshold was
estimated fromall of the trials in each staircase [17]. Twoquad-
rants of the stimulus, located on opposite sides of the fixation
point, contained 100% coherent motion, and the remaining
quadrants contained 0% coherent motion (Figure 1B). Stimuli
were created using the Psychophysics Toolbox [18, 19].
Each subject completed two courses of training (Figure 1C),
once while ingesting a pill containing 5 mg of donepezil before
every training session and once while an inactive placebo was
administered. Drug administration was double blind, and the
order of drug and placebo administration was counterbal-
anced between subjects. Each course of training was
preceded by 3 days of donepezil or placebo administration,
bringing drug plasma levels to within the steady-state range
(the half-life of donepezil in the human body is approximately
80 hr [20]), and drug or placebo administration continued daily
throughout training and the posttraining assessment. Before
and after training, thresholds were measured for both pairs
of visual field locations and for eight different directions of
motion.
For each course of training, subjects performed the task for
a particular stimulus with coherent motion in one direction and
in one of the two possible pairs of locations (Figure 1B).
Because training in this task is specific for visual field location
and motion direction [21], the effects of the two courses of
training were separately assessed in each subject by training
under donepezil with a stimulus presented in the other visual
field location and in the opposite motion direction than the
stimulus used for the placebo training course. Human subjects
exhibit differences in performance of this task for oblique and
cardinal directions of motion [21, 22]. We therefore used only
oblique directions for training. During training, participants
performed 1000 trials every day. Subjects underwent 5 days
of training, except for one subject who trained for 6 days in
both the placebo and donepezil conditions. At least 2 weeks
passed between the two courses of training, allowing for done-
pezil, if present, to be eliminated.
Figure 1. Experimental Procedure
(A) Task description. In each trial, two fields of dots with
100%coherent motion were sequentially presented. The
two fields contained either the same or slightly different
directions of motion.
(B) Stimulus configuration. Coherent motion was pre-
sented in one of two pairs of spatial locations (1 or 2)
and in the same direction of motion throughout the
course of training.
(C) Training procedure. Subjects participated in two
courses of training. Donepezil or placebo was adminis-
tered beginning 3 days before the pretraining measure-
ment and daily throughout training and the posttraining
measurement.
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mance for the trained condition, defined as the direction of
motion and visual field location used for training (Figure 2).
The average decrease in angular difference threshold
(Figure 1A) for the trained condition, combining placebo and
donepezil training courses, was 4.2 6 1.2. However, the
main effect of training (pre- versus posttraining thresholds,
across all directions of motion, both locations, and both drug
conditions [placebo and donepezil], as assessed by the
significance of the training factor in the analysis of variance
[ANOVA]) was not significant (F1,9 = 0.53, p = 0.49), demon-
strating the specificity of learning for the training stimulus.
To further characterize the specificity of learning, we
compared the improvement (change in threshold) that
occurred in the trained condition (combining drug and placebo
training courses), relative to the improvement that occurred in
performance of the task on other stimuli. Direction specificity
of perceptual learning was assessed by subtracting the
improvement in performance in the untrained directions of
motion (in the trained location) from the improvement in the
trained direction (in the trained location). This difference in
improvement was 2.7 6 0.9 (planned comparison, t36 =
3.26, p < 0.05), indicating that learning was specific to the
trained direction of motion.
A similar measure of location selectivity was also calculated
by subtracting the improvement in the untrained visual field
locations (in the trained direction) from the improvement in
the trained locations (in the trained direction). This difference
in improvement was 1.3 6 0.7 and was not significant
(planned comparison, t36 = 1.53, p = 0.13). The lack of location
specificity of learning for the combined donepezil and placebo
training courses replicates previous results in which this
paradigm showed substantial transfer of learning to visual field
locations immediately adjacent to the training location [21].
In addition, the spatial layout of our training stimulus, which
requires simultaneous discrimination of motion direction in
both visual hemifields, may have led to more spatial
generalization of learning than in previous studies.
Comparison of the drug and placebo conditions revealed
that administration of donepezil had an overall effect onlearning, as evidenced by a significant interac-
tion of drug and training factors in the ANOVA
(F1,9 = 5.89, p < 0.05; see Supplemental Exper-
imental Procedures). There were significant
reductions in threshold in the trained condition
following perceptual learning, both when
subjects were taking donepezil, with an
average improvement of 6.2 6 2.1 (plannedcomparison, t36 = 6.81, p < 0.05), and under placebo, 2.2
 6
0.8 (planned comparison, t36 = 2.42, p < 0.05). However, the
improvement in performance in the trained condition during
donepezil administration was significantly larger than the
improvement under placebo (planned comparison, t36 = 3.1,
p < 0.05).
In addition to enhancing the amount of learning in the trained
condition, donepezil also increased its selectivity to this condi-
tion. Direction and location selectivity were computed sepa-
rately for the placebo and donepezil training courses using
the same procedure described above for combined drug and
placebo data. Direction selectivity was 4.0 6 1.2 under done-
pezil (planned comparison, t36 = 3.94, p < 0.05) and 1.4
 6 1.1
under placebo (planned comparison, t36 = 1.34, p = 0.19). The
difference between these two values was statistically signifi-
cant, indicating that, compared to placebo, donepezil
increased the direction selectivity of learning (planned
comparison, t36 = 2.82, p < 0.05). Similarly, location selectivity
was 3.0 6 1.2 under donepezil (planned comparison, t36 =
2.36, p < 0.05) and 21.2 6 1.0 under placebo (planned
comparison, t36 = 0.92, p = 0.36). The increase in location spec-
ificity under donepezil (relative to placebo) was also statisti-
cally significant (planned comparison, t36 = 2.68, p < 0.05).
Comparisons of raw threshold values are sensitive to
between-subject performance differences and to effects of
the drug on overall task performance. In addition to donepe-
zil’s enhancement of the magnitude of perceptual learning,
there was an overall deleterious effect of donepezil on discrim-
ination thresholds (F1,9 = 12.76, p < 0.05, combining all
directions, both locations, and both pre- and posttraining
measurements, as assessed by the significance of the drug
factor in the ANOVA), whichmay stem from nonspecific effects
of cholinergic enhancement on visual perception and/or task
performance (see Discussion).
In particular, pretraining thresholds for the direction of
motion and visual field location used for training were numer-
ically higher under donepezil (13.3 6 2.4) than under placebo
(10.7 6 0.8), raising the possibility that the drug effect on the
magnitude of learning was due to this difference between do-
nepezil and placebo in pretraining thresholds. However, this
Figure 2. Effects of Training and Cholinergic Enhance-
ment with Donepezil on Motion Direction Discrimination
Thresholds
Each plot displays angular difference thresholds in
degrees (Figure 1A) for different directions of motion,
where 0 corresponds to the direction used for training.
There was a significant improvement in performance for
the trained condition (trained direction and visual field
location), and this improvement was substantially larger
under donepezil than under placebo. Error bars denote
standard error of the mean (SEM). Single-subject data
are presented in Figure S1.
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then used for training was not statistically significant (post
hoc t test: t11 = 1.17, p = 0.27). On the other hand, posttraining
thresholds for the trained condition were significantly lower
under donepezil (7.2 6 0.6) than under placebo (8.5 6
0.5, post hoc t test: t11 = 2.81, p < 0.05). There were no signif-
icant effects of the drug on thresholds for any other combina-
tion of visual field location and motion direction, either before
or after training. This finding provides additional evidence that
donepezil enhances perceptual learning in a stimulus-specific
manner, because any general effect of the drug on task perfor-
mance would presumably have affected both pre- and post-
training thresholds (see Supplemental Data for additional
analysis of donepezil’s effect on overall thresholds and
Figure S1 for individual subject data).
To isolate donepezil’s effects on perceptual learning from its
effects on overall task performance, we calculated the percent
learning for each subject relative to that subject’s pretraining
performance (Figure 3). Percent learning in the trained condi-
tion was greater for donepezil than for placebo (planned
comparison, t36 = 2.5, p < 0.05), further demonstrating that
the beneficial effects of donepezil on learning were not due
to the drug’s effects on overall performance.
Inorder todeterminewhether the increase in themagnitudeof
learning under donepezil was a consequence of more rapid
learning, we examined the progression of learning in the trainedcondition for both donepezil and placebo
(Figure 4). A single-parametermodel of learning
was fit to the data (see Supplemental Experi-
mental Procedures). Average learning rates
(in units of percent change/session) were
greater for donepezil (4.9% per session 6
0.8% per session) than for placebo (2.0% per
session6 0.5% per session). Statistical signifi-
cance of the effect of cholinergic enhancement
onlearningratewascalculatedusinganonpara-
metric permutation test (see Supplemental
Experimental Procedures). This test demon-
strated that learning was significantly more
rapid under donepezil (p < 0.05).
Discussion
Cholinesterase inhibitors such as donepezil
are commonly prescribed drug treatments for
Alzheimer’s disease. It would therefore
be beneficial to understand the specific
aspects of cognition and behavioral perfor-
mance that are enhanced by increases in
synaptic ACh. A previous study has shownthat administration of the cholinesterase inhibitor physostig-
mine to healthy humans enhanced the behavioral effects of
visual spatial attention [11], but another study reported no
effects of this drug on performance in tasks requiring visual
spatial attention [23]. Also, administration of physostigmine
[10], as well as donepezil [24], can improve long-term retention
of memorized items, but this effect has also not always been
found [25]. Our findings demonstrate the possibility of
enhancing the beneficial cognitive effects of the cholinergic
system, even in a young healthy population, and suggest
that the cognitive improvement associated with cholinergic
enhancement in Alzheimer’s disease may stem from an
augmented capacity to learn new information.
Studies in animals have shown that ACh increases transmis-
sion at feedforward thalamocortical synapses relative to
lateral intracortical connections [26]. ACh reduces the spatial
spread of excitatory activity following electrical stimulation
of rat visual cortical slices [27] and decreases the preferred
stimulus length of cells in marmoset area V1 [4]. In addition,
electrical stimulation of the basal forebrain results in a more
reliable representation of the stimulus in visual cortical
neurons [28]. In humans, donepezil reduces the spatial
spread of excitatory fMRI visual responses in early visual
cortex [5], consistent with a reduction in excitatory receptive
field size of visual cortical neurons, and physostigmine
increases the selectivity of responses in visual association
Figure 3. Donepezil Increases Magnitude and Specificity of Perceptual
Learning
Percent reduction in threshold following training was significantly larger
under donepezil in the trained condition, and learning under donepezil
was more specific to the direction of motion and visual field location used
for training. Error bars denote SEM. These data are presented without
normalization (i.e., raw threshold values) in Figure S2.
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learning, these increases in neural selectivity by ACh may
enhance learning-dependent changes in tuning of the neurons
that encode task-relevant stimuli. This is consistent with
previous models of the role of the cholinergic system in
learning and memory [29].
One factor that could be mediating the effects of cholinergic
transmission on learning is visual attention. Attention has been
found to play an important facilitatory role in some types of
perceptual learning [30], and ACh modulates allocation of
attention [1, 31]. In particular, when an animal is attending to
a particular visual field location, visual cortical neurons with
receptive fields at that location exhibit larger responses to
visual stimulation. This increase in firing rate due to visualFigure 4. Donepezil Increases Rate of Perceptual Learning
Percent learning in the trained condition is presented as a function of
training session. Training under donepezil (d) proceeded at a more rapid
rate than training under placebo (B). Learning rates were computed by
fitting a single-parameter model of learning to the data (gray continuous
lines, where the shaded area is the standard deviation derived from a jack-
knife estimate; see Supplemental Experimental Procedures). Error bars
denote SEM.spatial attention is augmented by local administration of ACh
to cortical area V1 and is attenuated following local administra-
tion of the muscarinic ACh receptor antagonist scopolamine
[32]. Previous studies in humans have shown increases in
the effects of sustained visual attention following pharmaco-
logical enhancement of the cholinergic system [11, 31]. In the
present study, donepezil may have facilitated processing of
the training stimulus through enhanced allocation of attention
to this stimulus, thereby augmenting perceptual learning.
Nevertheless, we cannot rule out the possibility that donepe-
zil’s enhancement of perceptual learning is due to a direct
modulation of plasticity rather than to an effect mediated by
attention.
It is important to note that perceptual learning does not
always require attention to be directed to the stimulus and
that learning can occur even in the absence of conscious
perception of the stimulus. Watanabe et al. [33] instructed
participants to perform a difficult sensory judgment in the
center of the visual field while a task-irrelevantmotion stimulus
was presented in the peripheral visual field. Although the
amount of coherent motion in the peripheral stimulus was
undetectable, subjects improved in performance of a motion
discrimination task for the direction of motion contained in
the peripheral stimulus, and the learning was specific to that
direction of motion. However, even for this kind of task-irrele-
vant perceptual learning, training was still not entirely sublim-
inal. Specifically, for the peripheral subthreshold stimuli,
learning occurred only when the peripheral stimulus was pre-
sented at the same time that the target appeared in central
vision [34]. That is, simultaneous presentation of task-relevant
information was required in order for plasticity of the neural
representations of the task-irrelevant stimulus to take place.
Furthermore, another study [35] demonstrated that task-
irrelevant perceptual learning depends on the relative visual
field locations of the task-irrelevant and task-relevant stimuli.
Task-irrelevant perceptual learning was demonstrated for
stimuli that were near the task-relevant stimulus but was not
observed for stimuli that were farther away (6.6 of visual
angle) from the attended stimulus. Acetylcholine is released
in cortex when animals are performing a task requiring
sustained attention [6], and a recent study showed that ACh
can be released in frontal cortex in a transient and spatially
specific manner and that this transient release of ACh
increases the probability of stimulus detection [36]. We
hypothesize that ACh release may facilitate task-irrelevant
perceptual learning when the task-irrelevant stimuli appear in
temporal and spatial proximity to the allocation of spatial
attention. Further research is needed to determine the role of
ACh in task-irrelevant perceptual learning (see [37] for a review
of perceptual learning, attention, and neuromodulatory
signals).
In the present study, subjects’ overall task performance
(across both trained and untrained conditions) was impaired
by administration of donepezil, indicating that the presumed
increase in selectivity of the neural response by ACh did not
translate into an overall improvement in motion direction
discrimination. However, the decrease in performance could
also be the result of other effects of the drug. Donepezil was
administered systemically in our study, and although this
drug is relatively selective for the form of cholinesterase
expressed in the central nervous system [38, 39], it may have
affected nonspecific task-related cognitive functions and
cholinergic synapses regulating processes such as lens
accommodation and pupil dilation [40]. These nonspecific
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conditions (including both pre- and posttraining measure-
ments) and therefore would have been independent of the
effect of donepezil on themagnitude and specificity of percep-
tual learning. Importantly, increased learning in the trained
condition under donepezil was observed even when perfor-
mance was normalized to each subject’s pretraining threshold
(Figure 3). Thus, overall differences in performance do not
account for the beneficial effects of the drug on perceptual
learning (see Supplemental Data).
In conclusion, we have shown that the magnitude, direction
and location specificity, and rate of perceptual learning of
a visual motion direction discrimination task are greater
when donepezil is administered during the training procedure.
These results demonstrate the possibility of enhancing the
beneficial cognitive effects of the cholinergic system, even in
a young, healthy population. Our finding that donepezil
increases the specificity of perceptual learning suggests that
ACh may augment plasticity and tuning in populations of
neurons that encode task-relevant stimulus features.Supplemental Information
Supplemental Information includes Supplemental Data, Supplemental
Experimental Procedures, and two figures and can be found with this article
online at doi:10.1016/j.cub.2010.08.027.
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